Cochlear Limited
CHEOY
Updated: 24/09/2026, 15:33:24
Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items. Founded in 1981, Cochlear Limited is headquartered in Sydney, Australia.
No summaries found.
- Share price
- $49.07
- Market cap
- $6.42B
- Exchange
- OTC
- Currency
- USD
- CEO
- Diggory William Howitt
- Employees
- 5,400
- IPO date
- 05/04/2010
- Beta
- 0.262
- Last dividend
- $0.00
- Day range
- $48.96 – $49.38
- 52-week range
- $31.82 – $98.49
- 1-day performance
- -2.00%
- 1-year performance
- 54.21%
- Current drawdown (1Y)
- -50.18%
- CIK
- N/A
- CUSIP
- 191459205
- ISIN
- US1914592050
- Created
- 07/12/2025, 03:17:17
- Last update
- 24/09/2026, 15:33:24
Track Cochlear Limited with an AI analyst
See which prediction-market events move CHEOY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants
PRNewsWire • STOCK • 29/05/2026, 16:13:00
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
Newsfile Corp • STOCK • 11/05/2026, 10:00:00
Cochlear Limited (CHEOY) Q3 2026 Sales/Trading Call Transcript
Seeking Alpha • STOCK • 22/04/2026, 20:00:39
Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact
Reuters • STOCK • 22/04/2026, 06:32:06
Cochlear North America Celebrates International Cochlear Implant Day with Announcement of 2026 Academic Scholarship Recipients
PRNewsWire • STOCK • 25/02/2026, 09:12:00